Daiwa Health Development, Inc. Announces Webinar with Dr. Fred Pescatore on Clinical Applications of RBAC
Daiwa Health Development, Inc. is thrilled to host an upcoming webinar featuring Dr. Fred Pescatore, a distinguished expert in integrative medicine. Scheduled for August 29, 2024, at 1 p.m. (PST) / 2 p.m. (MST) / 4 p.m. (EST), the session will explore the clinical applications of RBAC (Rice Bran Arabinoxylan Compound), a key ingredient in Daiwa’s flagship products.
“Dr. Pescatore’s extensive knowledge and reputation in integrative medicine make this webinar an invaluable opportunity for both health professionals and enthusiasts,” said a Daiwa Health Development spokesperson.
Celebrating over 30 years of commitment to advancing health through natural supplements, Daiwa Health Development continues to uphold its tradition of innovation and education. Founded by herbalist Yasuo Ninomiya, the company has long been a bridge between traditional Oriental medicine and modern scientific research. This webinar is a testament to that legacy, focusing on the clinical impact and benefits of RBAC.
RBAC, Daiwa’s proprietary ingredient, has become a cornerstone of their product line due to its distinctive health benefits. Dr. Fred Pescatore will offer an in-depth look at RBAC’s clinical applications, highlighting its functionality and effectiveness in a medical context.
“We are excited to share Dr. Pescatore’s expertise with our audience as part of our 20th anniversary celebrations,” the spokesperson added. “This event aligns with our mission to promote healthier lifestyles through premium, natural supplements.”
Daiwa Health Development is renowned for its meticulous approach to supplement production. Their products are crafted in small batches to ensure optimal purity and efficacy, reflecting their commitment to ethical sourcing and rigorous quality control.
RBAC, an immune-enhancing complex developed by Daiwa, has been shown in clinical studies to boost immune system activity by increasing white blood cell functionality. Research highlights that RBAC enhances Natural Killer (NK) cell function, boosts T and B lymphocyte counts, and strengthens macrophages and cytokines. The ingredient, derived from rice bran and modified by Shiitake mushroom enzyme, is recognized for its safety and effectiveness. These claims have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease.
To learn more and register for the webinar, visit the Daiwa Health Development website. Don’t miss this chance to gain expert insights into RBAC and its clinical applications from a leading figure in integrative medicine.
About Daiwa Health Development, Inc.
Daiwa Health Development, Inc. is dedicated to enhancing health through high-quality, natural supplements. With over three decades of experience, the company merges traditional Oriental medicine with cutting-edge scientific research to offer advanced health solutions. Operating globally, Daiwa maintains a focus on ethical practices and top-tier product quality.
